Research graph
References from Gut microbiota–host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies. Local targets link to admitted publications; unresolved targets remain external evidence.
Insulin resistance in type 2 diabetes mellitus
10.1038/s41574-025-01114-y · 2025 · External reference
Spermidine mitigates immune cell senescence and boosts vaccine responses in healthy older adults-a pilot study
10.1111/acel.70545 · 2026 · External reference
Systems biology and microbiome innovations for personalized diabetic retinopathy management
10.1038/s41540-025-00607-w · 2025 · External reference
Clinical value of IL-17-targeted intervention in tissue injury repair: from bidirectional mechanisms to therapeutic strategies
10.3389/fimmu.2026.1773504 · 2026 · External reference
Nutritional regulation of microbiota-derived metabolites: implications for immunity and inflammation
10.1016/j.immuni.2023.12.009 · 2024 · External reference
Modulation of gut microbiota through dietary fibers to enhance regulatory T cell-based immunotherapy in GVHD following hematopoietic stem cell transplantation
10.3390/nu18081216 · 2026 · External reference
Probiotics and synbiotics for glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled trials
10.1016/j.clnu.2024.03.006 · 2024 · External reference
Interplay between insulin resistance and immune dysregulation in type 2 diabetes mellitus: implications for therapeutic interventions
10.2147/itt.s499605 · 2025 · External reference
The barrier and beyond: roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis
10.1080/19490976.2022.2052699 · 2022 · External reference
Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
10.1007/s00394-020-02282-5 · 2020 · External reference
An overview of obesity-related complications: the epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
10.1111/dom.16263 · 2025 · External reference
Polyamines regulate adaptive antitumor immunity by functional specialization of regulatory T cells
10.1016/j.immuni.2025.07.007 · 2025 · External reference
Global Sirt5 deletion reshapes gut microbiota and impairs glucose metabolism in high-fat diet-induced obese mice
10.1016/j.bbrc.2025.153095 · 2026 · External reference
Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: myocellular mechanisms involved
10.1007/s11154-025-09954-9 · 2025 · External reference
LPS priming-induced immune tolerance mitigates LPS-stimulated microglial activation and social avoidance behaviors in mice
10.1016/j.jphs.2024.02.006 · 2024 · External reference
Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions
10.1038/emm.2017.282 · 2018 · External reference
Gut microbial metabolites in inflammatory bowel disease: immunological mechanisms regulating Treg/Th17 balance and therapeutic potential
10.3389/fimmu.2026.1780865 · 2026 · External reference
Common mechanisms of Gut microbe-based strategies for the treatment of intestine-related diseases: based on multi-target interactions with the intestinal barrier
10.1186/s12964-025-02299-5 · 2025 · External reference
Insulin as an accelerator and brake of aging: from molecular landscape to clinical interventions
10.1002/cph4.70079 · 2025 · External reference
Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation
10.3389/fendo.2026.1856667 · 2026 · External reference
Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
10.1186/s13578-023-01046-y · 2023 · External reference
Dual functions of Treg in the mucosal barrier and lung cancer microenvironment and prospects for targeted therapy
10.1111/imm.70140 · 2026 · External reference
Mapping bacterial extracellular vesicle research: insights, best practices and knowledge gaps
10.1038/s41467-024-53279-1 · 2024 · External reference
Role of mucosal immunity and epithelial-vascular barrier in modulating gut homeostasis
10.1007/s11739-023-03329-1 · 2023 · External reference
Effects of gut microbiota-derived extracellular vesicles on obesity and diabetes and their potential modulation through diet
10.1007/s13105-021-00837-6 · 2022 · External reference
Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases
10.1007/s11010-024-05077-y · 2025 · External reference
Changes in peripheral immune cell phenotypes and their roles in autism: insights from clinical and animal model studies
10.1038/s41380-025-03349-7 · 2026 · External reference
Gut microflora modulates Th17/Treg cell differentiation in experimental autoimmune prostatitis via the short-chain fatty acid propionate
10.3389/fimmu.2022.915218 · 2022 · External reference
Obesity management in adults: a review
10.1001/jama.2023.19897 · 2023 · External reference
Postbiotic impact on host metabolism and immunity provides therapeutic potential in metabolic disease
10.1210/endrev/bnae025 · 2025 · External reference
Exercise intervention regulates gut microbiota to improve type 2 diabetes: a narrative review of the mechanisms
10.3389/fnut.2025.1698112 · 2025 · External reference
The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective
10.3389/fimmu.2023.1277102 · 2023 · External reference
Type 2 diabetes mellitus as a multisystem disease: from insulin resistance to organ crosstalk-a narrative review
10.3390/biomedicines14040752 · 2026 · External reference
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers
10.1007/s00281-024-01027-4 · 2024 · External reference
Microbiota transplantation in individuals with type 2 diabetes and a high degree of insulin resistance
10.3390/nu16203491 · 2024 · External reference
Tumor-produced ammonia is metabolized by regulatory T cells to further impede anti-tumor immunity
10.1016/j.cell.2025.11.034 · 2026 · External reference
Host-gut microbiota interactions in health and disease: mechanisms and intervention strategies
10.3389/fmicb.2026.1785607 · 2026 · External reference
A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial
10.1007/s00125-024-06272-8 · 2025 · External reference
Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions
10.1128/cmr.00048-26 · 2026 · External reference
Fecal microbiota transplantation: a tale of two regulatory pathways
10.1080/19490976.2025.2493901 · 2025 · External reference
Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021 with forecasts to 2050
10.3389/fendo.2025.1538143 · 2025 · External reference
The prebiotic potential of inulin-type fructans: a systematic review
10.1093/advances/nmab119 · 2022 · External reference
Bacterial extracellular vesicles: potential therapeutic applications, challenges, and future prospects
10.1002/jobm.202400221 · 2024 · External reference
A pilot study on the metabolic impact of mediterranean diet in type 2 diabetes: is gut microbiota the key?
10.3390/nu13041228 · 2021 · External reference
Comparative efficacy and safety of probiotics, prebiotics, and synbiotics for type 2 diabetes management: a systematic review and network meta-analysis
10.1016/j.dsx.2023.102923 · 2024 · External reference
The AhR/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects
10.3389/fimmu.2025.1668173 · 2025 · External reference
The role of microbiota derived metabolites in modulating diabetic inflammation: a systematic review
10.1007/s10735-026-10775-6 · 2026 · External reference
Effects of a mediterranean diet on the gut microbiota and microbial metabolites: a systematic review of randomized controlled trials and observational studies
10.1080/10408398.2022.2057416 · 2023 · External reference
Microbiome engineering: unlocking therapeutic potential in inflammatory bowel disease
10.3389/fmicb.2025.1610029 · 2025 · External reference
Type 1 and type 2 diabetes mellitus: commonalities, differences and the importance of exercise and nutrition
10.3390/nu15194279 · 2023 · External reference
Harnessing mucosal immunity for protective vaccines
10.1038/s41577-026-01273-7 · 2026 · External reference
Mediterranean diet, gut microbiota, and type 2 diabetes: a systematic review and meta-analysis of intervention trials
10.1016/j.numecd.2025.104433 · 2026 · External reference
Gut microbial metabolite deoxycholic acid facilitates Th17 differentiation through modulating cholesterol biosynthesis and participates in high-fat diet-associated colonic inflammation
10.1186/s13578-023-01109-0 · 2023 · External reference
The effects of probiotics supplementation on glycaemic control among adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials
10.1186/s12967-023-04306-0 · 2023 · External reference
Gut microbiota-derived metabolites modulate Treg/Th17 balance: novel therapeutic targets in autoimmune diseases
10.3389/fimmu.2025.1710733 · External reference
Metabolic dysregulation reshapes the immune landscape: the gut microbiota-mTOR axis in respiratory viral infection immunity
10.1016/j.ymthe.2025.12.033 · 2026 · External reference
Differential effects of inulin and fructooligosaccharides on gut microbiota composition and glycemic metabolism in overweight/obese and healthy individuals: a randomized, double-blind clinical trial
10.1186/s12916-025-04189-6 · External reference
Immunomodulatory actions of tonifying polysaccharides: pharmacological effects, mechanisms and therapeutic applications
10.3389/fimmu.2025.1640679 · External reference
Gut microbiota in exercise-regulated development, progression, and management of type 2 diabetes mellitus: a review of the role and mechanisms
10.12659/msm.947511 · 2025 · External reference
Targeting tumor-infiltrating regulatory T cells based on immunometabolism
10.20892/j.issn.2095-3941.2025.0645 · 2026 · External reference
A mouse model to distinguish NLRP6-mediated inflammasome-dependent and -independent functions
10.1073/pnas.2321419121 · 2024 · External reference
A DNA-based nanodevice senses purinergic signaling and drives an immune switch for resolving inflammation
10.1038/s41467-026-68879-2 · 2026 · External reference
Gut microbiome and metabolic health: mechanisms and precision interventions
10.1080/19490976.2026.2644677 · 2026 · External reference
Pleiotropic immunoregulation by bile acids in pathophysiology
10.3389/fimmu.2026.1719092 · 2026 · External reference
Regulatory T cells and peripheral immune tolerance: key mechanisms and therapeutic strategies for cardiovascular diseases
10.3389/fimmu.2026.1776040 · 2026 · External reference
Exercise-induced modulation of gut microbiota in individuals with obesity and type 2 diabetes: a systematic review and meta-analysis
10.3389/fmicb.2025.1671975 · 2025 · External reference
Decoding the gut microbiota-immune dialogue: from bidirectional axis to therapeutic applications
10.1186/s12951-026-04376-4 · 2026 · External reference
Bile acid metabolites control Th17/Treg balance in primary biliary cholangitis: mechanisms of disease progression and therapeutic targets
10.1111/jgh.70189 · 2026 · External reference
Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD
10.1016/j.cmet.2025.10.017 · 2025 · External reference
Diet components, immune function and IgE-mediated food allergy
10.3390/nu17233669 · 2025 · External reference
TLR4 interaction with PIEZO1 facilitates the 5-HT-mediated intestinal motility dysfunction in offspring mice induced by LPS exposure during pregnancy
10.1016/j.gendis.2025.101707 · 2025 · External reference
Immune cell contribution to vascular complications in diabetes
10.3389/fendo.2025.1549945 · 2025 · External reference
Anti-inflammatory diets in metabolic syndrome and obesity: multi-omics perspectives on the interplay between gut microbiota, DNA methylation, and adipokine regulation-a narrative review
10.3390/ijms27062734 · 2026 · External reference
Resident and migratory adipose immune cells control systemic metabolism and thermogenesis
10.1038/s41423-021-00804-7 · 2022 · External reference
High-fat diet-induced adipose tissue-resident macrophages, T cells, and dendritic cells modulate chronic inflammation and adipogenesis during obesity
10.3389/fimmu.2025.1524544 · 2025 · External reference
The interplay of dietary fibers and intestinal microbiota affects type 2 diabetes by generating short-chain fatty acids
10.3390/foods12051023 · 2023 · External reference
Role of the Th2-like immune response in obesity: IL-4 as a metabolic regulator and IL-13 as an effector of muscle energy metabolism
10.3390/biomedicines13092208 · 2025 · External reference
Probiotics as modulators of intestinal barrier integrity and immune homeostasis: a comprehensive review
10.1002/jsfa.70168 · 2026 · External reference
Resident microbes shape host immunity and protect against pathogen infection and inflammatory disease
10.1007/s00018-026-06219-9 · 2026 · External reference
The role of gut microbiota and bacterial translocation in the pathogenesis and management of type 2 diabetes mellitus: mechanisms, impacts, and dietary therapeutic strategies
10.1016/j.physbeh.2025.114838 · 2025 · External reference
Immunomodulatory effects of selected non-nutritive bioactive compounds and their role in optimal nutrition
10.3390/cimb47020089 · 2025 · External reference
Probiotics and synbiotics supplementation improve glycemic control parameters in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials
10.1016/j.phrs.2022.106399 · 2022 · External reference
Revisiting the donor screening protocol of faecal microbiota transplantation (FMT): a systematic review
10.1136/gutjnl-2023-329515 · 2024 · External reference
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
10.1038/nm.1964 · 2009 · External reference
Mechanisms of acupuncture in the treatment of type 2 diabetes mellitus: insights from the regulation of the gut microecology
10.3389/fimmu.2025.1682521 · 2025 · External reference
Role of succinate dehydrogenase in age-related Th17 inflammation
10.1111/acel.70451 · 2026 · External reference
Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)
10.3389/fimmu.2022.1001956 · 2022 · External reference
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation
10.1007/s00281-024-01026-5 · 2024 · External reference
From immune activation to disease progression: unraveling the complex role of Serum Amyloid A proteins
10.1016/j.cytogfr.2025.03.003 · 2025 · External reference
Non-starch polysaccharides from Castanea mollissima Bl. ameliorate metabolic syndrome by remodeling barrier function, microbial community, and metabolites in high-fat-diet/streptozotocin-induced diabetic mice
10.1016/j.foodres.2024.115638 · 2025 · External reference
Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabetes mellitus: a randomized, double blind, controlled trial
10.3389/fendo.2024.1440286 · 2024 · External reference
Dendritic cells: orchestrators of immune responsiveness and tolerance
10.1111/imr.70073 · 2025 · External reference
REG/Reg family proteins: mediating gut microbiota homeostasis and implications in digestive diseases
10.1080/19490976.2025.2568055 · 2025 · External reference
Role of B cells as antigen presenting cells
10.3389/fimmu.2022.954936 · 2022 · External reference
IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches
10.1126/science.aaf4822 · 2016 · External reference
Therapeutic strategies to modulate gut microbial health: approaches for chronic metabolic disorder management
10.3390/metabo15020127 · 2025 · External reference
Microbiome engineering: engineered live biotherapeutic products for treating human disease
10.3389/fbioe.2022.1000873 · 2022 · External reference
TH17 cell heterogeneity and its role in tissue inflammation
10.1038/s41590-022-01387-9 · 2023 · External reference
Modulation of host immunity by microbiome-derived indole-3-propionic acid and other bacterial metabolites
10.1002/eji.202451594 · 2025 · External reference
Effects of probiotic and synbiotic supplementation on glycemic indices in adult individuals with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review and dose-response meta-analysis of RCTs
10.1007/s12602-025-10644-w · 2026 · External reference
multifaceted role of microbiota-derived indole-3-acetic acid in human diseases and its potential clinical application
10.1096/fj.202500295r · 2025 · External reference
Emerging mechanisms of obesity-associated immune dysfunction
10.1038/s41574-023-00932-2 · 2024 · External reference
The intestinal immune system and gut barrier function in obesity and ageing
10.1111/febs.16558 · 2023 · External reference
Bidirectional crosstalk between intestinal epithelium and immune microenvironment in inflammatory bowel disease: mechanisms and therapeutic implications
10.2147/jir.s538988 · 2026 · External reference
Indole-3-acetic acid alters intestinal microbiota and alleviates ankylosing spondylitis in mice
10.3389/fimmu.2022.762580 · 2022 · External reference
Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity
10.3389/fimmu.2022.1044737 · 2023 · External reference
Inflammation and insulin resistance
10.1172/jci29069 · 2006 · External reference
Engineered probiotics: applications and biological containment
10.1146/annurev-food-030216-030256 · 2017 · External reference
Gut microbiome predicts personalized responses to dietary fiber in prediabetes: a randomized, open-label trial
10.1038/s41467-025-66498-x · 2025 · External reference
Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial
10.1186/s13073-022-01030-0 · 2022 · External reference
Interactions of IDO and the kynurenine pathway with cell transduction systems and metabolism at the inflammation-cancer interface
10.3390/cancers15112895 · 2023 · External reference
Clinical effectiveness and cost-impact after 2 years of a ketogenic diet and virtual coaching intervention for patients with diabetes
10.1111/dom.15401 · 2024 · External reference
IgA and the gut-vagina axis
10.3389/fimmu.2025.1547303 · 2025 · External reference
Microbial metabolites and gut immunology
10.1146/annurev-immunol-090222-102035 · 2024 · External reference
Structure-function effects of different pectin chemistries and its impact on the gastrointestinal immune barrier system
10.1080/10408398.2023.2290230 · 2025 · External reference
Immunology of chronic low-grade inflammation: relationship with metabolic function
10.1530/joe-22-0271 · 2023 · External reference
Bacterial cell envelope components of gut commensals: effects in host-microbe interaction
10.1080/07853890.2026.2618429 · 2026 · External reference
Effect of probiotic extracellular vesicles and their applications on health and disease
10.1002/jsfa.14123 · External reference
Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch
10.1038/s41590-025-02166-y · External reference
Mechanism of immune attack in the progression of obesity-related type 2 diabetes
10.4239/wjd.v14.i5.494 · 2023 · External reference
Associated factors and principal pathophysiological mechanisms of type 2 diabetes mellitus
10.3389/fendo.2025.1499565 · External reference
Longan polysaccharides promote Th1 and Treg cell differentiation via dendritic cells
10.1016/j.ijbiomac.2025.146462 · External reference
Interleukin-22: the hub bridging gut homeostasis and metabolism
10.1016/j.it.2025.10.009 · 2026 · External reference
Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease
10.3389/fimmu.2025.1591151 · External reference
Lactate signaling and immune suppression in tumors: mechanisms and therapeutic implications
10.1007/s13402-026-01186-6 · 2026 · External reference
Remodeling mechanisms and intervention strategies of the oral mucosal immune barrier
10.3389/fimmu.2026.1815513 · 2026 · External reference
Sodium butyrate ameliorates sepsis-associated lung injury by enhancing gut and lung barrier function in combination with modulation of CD4+Foxp3+ regulatory T cells
10.1016/j.ejphar.2023.176219 · 2024 · External reference
Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches
10.1002/jev2.12404 · 2024 · External reference
Controlled colonization of the human gut with a genetically engineered microbial therapeutic
10.1126/science.adu8000 · 2025 · External reference
Opportunities and challenges in phage therapy for cardiometabolic diseases
10.1016/j.tem.2024.03.007 · 2024 · External reference
Lipid metabolic disorders: a pivotal driver in type 2 diabetes mellitus pathogenesis
10.1007/s13679-026-00732-5 · 2026 · External reference
Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study
10.3389/fcimb.2022.1089991 · 2023 · External reference
Biomimetic strategies of cell membrane vesicles driven by pathogen-host interactions: novel insights into antimicrobial immunotherapy and infection prevention
10.3389/fimmu.2025.1681889 · 2025 · External reference
When short-chain fatty acids meet type 2 diabetes mellitus: revealing mechanisms, envisioning therapies
10.1016/j.bcp.2025.116791 · 2025 · External reference
The multifaceted ILC3s: key regulator of mucosal defense and homeostasis
10.1016/j.celrep.2026.117472 · 2026 · External reference
Commensal Bacillus pumilus SE5-derived peptidoglycan and lipoteichoic acid showed synergistic effects in improving growth, immunity, and intestinal health of grouper (Epinephelus coioides)
10.1007/s12602-024-10291-7 · 2025 · External reference
Recent advances in the effect of adipose tissue inflammation on insulin resistance
10.1016/j.cellsig.2024.111229 · 2024 · External reference
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer
10.1038/s41467-025-63146-2 · 2025 · External reference
Immune activation induced by dysregulated lipid metabolism in the pathogenesis of type 2 diabetes
10.4239/wjd.v16.i12.114395 · 2025 · External reference
The modulation and mechanism of probiotic-derived polysaccharide capsules on the immune response in allergic diseases
10.1080/10408398.2022.2062294 · 2023 · External reference
Gut microbial metabolites on host immune responses in health and disease
10.4110/in.2023.23.e6 · 2023 · External reference
The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation
10.3389/fimmu.2025.1519925 · 2025 · External reference
Multifaceted therapeutic potential of saponins in type 2 diabetes mellitus: mechanisms targeting insulin resistance and diabetic complications
10.3389/fphar.2026.1793697 · 2026 · External reference
Role and progression of bile acid metabolism in mediating Th17/Treg homeostasis in inflammatory bowel disease
10.1016/j.isci.2026.114961 · 2026 · External reference
The mechanism underlying the influence of indole-3-propionic acid: a relevance to metabolic disorders
10.3389/fendo.2022.841703 · 2022 · External reference
Current status and future prospects on nanodelivery systems targeting the small intestine for absorption of bioactive substances
10.3390/foods14183234 · 2025 · External reference
Bacterial outer membrane vesicles in potentiating cancer vaccines: progress and prospects
10.1002/advs.202521684 · 2026 · External reference
Metabolic regulation of the Th17/Treg balance in inflammatory bowel disease
10.1016/j.phrs.2024.107184 · 2024 · External reference
Research progress on regulatory mechanisms of mucosal barriers and their applications in allergic diseases
10.3389/fimmu.2026.1671677 · 2026 · External reference
Advanced oral drug delivery systems for gastrointestinal targeted delivery: the design principles and foundations
10.1186/s12951-025-03479-8 · 2025 · External reference
Macrophage metabolic reprogramming in inflammatory bowel diseases: from pathogenesis to therapy
10.2147/jir.s534447 · 2025 · External reference
Diabetes and its complications: molecular mechanisms, prevention and treatment
10.1038/s41392-025-02401-w · 2026 · External reference
The role of polysaccharides in immune regulation through gut microbiota: mechanisms and implications
10.3389/fimmu.2025.1555414 · 2025 · External reference
Unlocking the power of postbiotics: a revolutionary approach to nutrition for humans and animals
10.1016/j.cmet.2024.03.004 · 2024 · External reference
Review on bacterial outer membrane vesicles: structure, vesicle formation, separation and biotechnological applications
10.1186/s12934-025-02653-9 · 2025 · External reference
Dietary carbohydrates and the intestinal barrier: emerging insights into NF-κB modulation and health outcomes
10.1021/acs.jafc.5c06354 · 2025 · External reference
Possible immune mechanisms of gut microbiota and its metabolites in the occurrence and development of immune thrombocytopenia
10.3389/fmicb.2024.1426911 · 2024 · External reference
Systemic effects of type 2 diabetes therapies: an integrated perspective on the cardio-renal- cerebral-metabolic axis
10.3389/fmed.2026.1746457 · 2026 · External reference
Multi-strain probiotics BLa80, LRa05, and BBr60 modulate inflammation, bile acids, and gut microbiota in type 2 diabetes: a randomized controlled trial
10.1002/fsn3.71735 · 2026 · External reference
Advances in biological functions and applications of feeding microorganism-derived extracellular vesicles
10.1007/s12602-025-10864-0 · 2026 · External reference
Changes of Th17 cells, regulatory T cells, Treg/Th17, IL-17 and IL-10 in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
10.1007/s12020-022-03043-6 · 2022 · External reference
The role of fecal microbiota transplantation (FMT) in the management of metabolic diseases in humans: a narrative review
10.3390/biomedicines12081871 · 2024 · External reference
Guapian tea polysaccharides boost immunity and augment intestinal barrier integrity in cyclophosphamide-induced mice
10.1016/j.ijbiomac.2026.152842 · 2026 · External reference
